Search

Your search keyword '"Torres-Rodríguez JM"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Torres-Rodríguez JM" Remove constraint Author: "Torres-Rodríguez JM"
101 results on '"Torres-Rodríguez JM"'

Search Results

1. The utility of serology in diagnosing candidosis in non-neutropenic critically ill patients.

2. Respiratory allergy to fungi in Barcelona, Spain: clinical aspects, diagnosis and specific treatment in a general allergy unit.

3. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].

4. Müeller-Hinton methylene blue media as an alternative to RPMI 1640 for determining the susceptibility of Cryptococcus neoformans and Cryptococcus gattii to posaconazole with Etest.

5. [Histoplasmosis 45 years after infection in an immunocompetent man].

6. Prevalence of tinea pedis, tinea unguium of toenails and tinea capitis in school children from Barcelona.

7. MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii.

8. Disseminated histoplasmosis by Histoplasma capsulatum var. duboisii in a paediatric patient from the Chad Republic, Africa.

9. [Candiduria in type 2 diabetes mellitus patients and its clinical significance. Candida spp. antifungal susceptibility].

10. Laccase activity in Cryptococcus gattii strains isolated from goats.

11. MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.

12. [Urease activity in Cryptococcus neoformans and Cryptococcus gattii].

13. [Thirty years of the "Asociación Española de Micología"].

14. In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre Yeast One and standard CLSI (NCCLS) M27-A2 methods.

15. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.

16. [Nasal fungal microbiota in allergic and healthy subjects].

17. [Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].

18. Successful treatment of an Aspergillus fumigatus Infection with voriconazole via a nasogastric tube.

19. Seasonal distribution of Alternaria, Aspergillus, Cladosporium and Penicillium species isolated in homes of fungal allergic patients.

20. Successful thermotherapy for a subcutaneous infection due to Alternaria alternata in a renal transplant recipient.

21. Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.

22. DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.

23. First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain.

24. [In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].

25. [Histoplasma capsulatum infection in a group of travelers to Guatemala].

26. Early diagnosis of candidiasis in non-neutropenic critically ill patients.

28. [Lung aspergillosis. Role of the corticoids as associated risk factor in the patient with chronic bronchitis].

29. Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model.

30. In vitro susceptibility of Cryptococcus neoformans serotypes to GM 237354 derivative of the sordarin class.

31. [Candiduria in patients with urethral catheter admitted in Intensive Care Unit. Etiology and in vitro susceptibility to fluconazole].

32. [Epidemiological study of cryptococcosis in Spain: first results].

33. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].

34. Changes in androgenic steroid profile due to urine contamination by microorganisms: a prospective study in the context of doping control.

35. Antigens of Fusarium solani: types and criteria for immunochemical characterization.

36. [Diagnostic usefulness of the intradermal test with histoplamin in non-endemic areas of histoplasmosis].

37. In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method.

38. [Candidemia in AIDS. A retrospective study of nine cases].

39. Successful treatment with liposomal amphotericin B of an intraabdomianl abscess due to Candida norvegensis associated with a Gore-Tex mesh infection.

40. Antifungal compounds: controversies, queries and conclusions.

41. [Unusual fungal species causing onychomycosis.].

44. Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients.

45. In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.

46. Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in Spain.

47. [Topical treatment with eberconazole of the experimental guinea pig cutaneous candidosis.].

49. [Oral terbinafine for the tinea unguium of the toenails. Efficacy between 12 and 24 weeks of treament.].

50. [Spectophotometric method for preparing the inocula of dematiaceous fungi.].

Catalog

Books, media, physical & digital resources